StockData

L3Harris Technologies vs Northrop Grumman

LHX and NOC side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How LHX and NOC compare

Northrop Grumman is the larger company, worth 1.6 times as much as L3Harris Technologies ($78.6B against $48.5B).

On earnings, Northrop Grumman is cheaper: it trades at 17.5× trailing earnings, against 24.3× for L3Harris Technologies.

Northrop Grumman grew revenue faster over the last twelve months (6.5% versus 5.3% for L3Harris Technologies).

Northrop Grumman keeps more of each dollar of sales as profit, with a net margin of 10.4% compared with 5.2% at L3Harris Technologies.

Both pay dividends: L3Harris Technologies yields 1.4% and Northrop Grumman 1.7%.

L3Harris Technologies scores higher on the StockData Score (19 against 18 for Northrop Grumman), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricLHXNOC
Size and price
Market cap$48.5B$78.6B
Share price$260.74$553.26
Change, 1 year−9.9%−0.85%
Change, 5 years21.2%56.3%
Beta (5Y)0.450.43
Employees45K95K
StockData Score
Total score19 (better)18
Valuation score6 (better)3
Growth score3 (better)2
Performance score35 (better)
Health score34 (better)
Dividend score44
Valuation
P/E24.3×17.5× (better)
P/S1.2× (better)1.8×
P/B2.4× (better)4.2×
EV/EBITDA10.6× (better)14.6×
P/FCF13.3× (better)20.5×
PEG1.54–
FCF yield7.5% (better)4.9%
Fair value$357.80$649.75
Margin of safety27.1% (better)14.9%
Growth
Revenue growth (TTM)5.3%6.5% (better)
Revenue growth, 5Y average–2.7%
Net income growth (TTM)16.2% (better)12.5%
EPS growth (TTM)15.1% (better)14.0%
EPS growth, 5Y average1.6%8.9% (better)
Profitability
Gross margin25.6%–
Operating margin10.6% (better)10.6%
Net margin5.2%10.4% (better)
FCF margin9.2% (better)8.8%
Return on equity10.3%26.1% (better)
Return on invested capital12.8%13.3% (better)
Financial health
Debt / equity0.54 (better)0.81
Net debt / EBITDA1.49 (better)1.86
Current ratio1.201.23 (better)
Altman Z-score2.723.09 (better)
Piotroski F-score7 (better)6
Dividends and buybacks
Dividend yield1.4%1.7% (better)
Payout ratio45.5%30.2%
Years of dividend growth416 (better)
Dividend growth, 5Y average–9.7%
Buyback yield1.6% (better)0.67%
Shareholder yield3.0% (better)2.4%
Ownership
Held by institutions87.9%83.5%
Held by insiders0.32%0.22%
Insider net buying, 12 months−$7.5M (better)−$26.4M
Superinvestors holding11
Short interest, % of float2.2%1.5%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.